Search results for "Genotype Distribution"

showing 2 items of 2 documents

Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy.

2009

We determined the prevalence of human papillomavirus (HPV) cervical infection and HPV genotypes among 115 women immigrating to Sicily (Italy), with regard to abnormal cytology and socio-behavioral characteristics in a cross-sectional, observational study. Information was collected with the help of cultural mediators/translators. HPV-DNA was assayed by the INNOLiPA HPV assay and a nested PCR/sequencing method. Sixty (52.2%) women came from sub-Saharan Africa and 55 (47.8%) from Eastern Europe. HPV infection was found in 55 (47.8%) women. The most frequent types were the oncogenic types HPV-16 (7.8%), HPV-18 and 51 (6.0% each), HPV-52 (5.2%), 31, 53, and 68 (4.3% each). Twenty-seven (23.5%) w…

Adultmedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypePrevalenceCervicitisEmigrants and ImmigrantsUterine Cervical NeoplasmsCervix UteriSettore MED/01 - Statistica MedicaUterine Cervical DiseasesYoung AdultEpidemiologyGenotypemedicinePrevalenceHumansEurope EasternCervixPapillomaviridaeCervical cancerGynecologybusiness.industryObstetricsPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and GynecologyGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsmedicine.anatomical_structureCervical HPV infection HPV genotype distribution immigrant womenCross-Sectional StudiesItalyAfricaFemalebusinessNested polymerase chain reactionActa obstetricia et gynecologica Scandinavica
researchProduct

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020

2022

Background Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given current trends. Methods This analysis includes a literature review, Delphi process, and mathematical modelling to estimate HCV prevalence (viraemic infection, defined as HCV RNA-positive cases) and the cascade of care among people of all ages (age =0 years from birth) for the period between Jan 1, 2015, and Dec 31, 2030. Epidemiological data were collected from published …

Viremia/epidemiologyGenotype DistributionHepatitis C/epidemiologyHepatologyEpidemiologyGastroenterologyInfant NewbornCOVID-19HepacivirusHepatitis ATodays Treatment ParadigmInfectionsHepatitis CFuture Disease BurdenSDG 3 - Good Health and Well-beingHCVfuture disease burden ; todays treatment paradigm ; genotype distribution ; epidemiology ; infectionsPrevalenceHumansHuman medicineViremiaPandemicsCOVID-19/epidemiologyThe Lancet Gastroenterology and Hepatology
researchProduct